Form 4: Lemaitre Vascular Insider Acquires Dividend Rights

Sentiment:

Insider Transaction Report


Lemaitre Vascular President and Director David B. Roberts acquired additional dividend equivalent rights tied to his equity awards.

Summary

  • David B. Roberts, President and Director of Lemaitre Vascular Inc. (LMAT), reported the acquisition of Dividend Equivalent Rights (DERs).
  • The transactions occurred on March 26, 2026, and involved the accrual of DERs on various restricted stock unit (RSU) and performance share unit (PSU) awards.
  • A total of 18.0821 Dividend Equivalent Rights were acquired across nine separate entries.
  • Each dividend equivalent right is the economic equivalent of one share of Lemaitre Vascular's common stock.
  • These DERs vest proportionately with their underlying RSU and PSU awards, which were granted on various dates between December 2022 and December 2025.
  • Following these transactions, David B. Roberts beneficially owns a total of 120.5978 derivative securities in the form of Dividend Equivalent Rights.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine disclosure of executive compensation, reflecting the accrual of dividend equivalent rights on existing equity awards, and does not indicate a significant change in company fundamentals or strategy.

Future Outlook

NA

Industry Context

StockSavvy.ai notes this is a standard disclosure for executive compensation, reflecting the routine accrual of dividends on unvested equity awards, which is a common practice in many publicly traded companies to align executive incentives with shareholder returns.

Stakeholder Impact

  • Minimal impact on shareholders, as this is a routine disclosure related to executive compensation and does not represent a new strategic or operational development.

Key Dates

DateDescription
12/12/2022Grant date of underlying restricted stock unit and performance share unit awards on which dividend equivalent rights accrued.
12/8/2023Grant date of underlying restricted stock unit and performance share unit awards on which dividend equivalent rights accrued.
12/6/2024Grant date of underlying restricted stock unit and performance share unit awards on which dividend equivalent rights accrued.
2/18/2025Grant date of underlying restricted stock unit and performance share unit awards on which dividend equivalent rights accrued.
12/10/2025Grant date of underlying restricted stock unit award on which dividend equivalent rights accrued.
03/26/2026Date of acquisition of Dividend Equivalent Rights.
03/30/2026Signature date of the reporting person's attorney-in-fact.

Keywords

Lemaitre Vascular, LMAT, Insider Transaction, Form 4, Dividend Equivalent Rights, Executive Compensation, David B. Roberts

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.